• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

27.88 +0.02 (+0.07%)
Official Closing Price Updated: 7:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 860,353
Open 27.92
Bid (Size) 25.82 (100)
Ask (Size) 28.64 (100)
Prev. Close 27.86
Today's Range 27.61 - 27.95
52wk Range 26.12 - 37.51
Shares Outstanding N/A
Dividend Yield 2.24%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
October 06, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
September 23, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire

Performance

52-Week Range 25.7% below 52-week high
27.88
26.1252W Low 37.5152W High
1 Week 0.3% below 1-week high
26.461W Low 27.961W High

Smith & Nephew SNATS, Inc. Common Stock (SNN) traded between $26.12 and $37.51 over the past 52 weeks and last traded at $27.88, 25.7% below its 52-week high. Over the past week it ranged between $26.46 and $27.96.

Past 12 Months
+3.4%
-1.8%
-9.5%
-18.5%
-15.2%
-20.9%
1W +$0.92
1M -$0.52
3M -$2.92
6M -$6.34
YTD -$5.00
1Y -$7.38

SNN was -20.9% over the past year, -18.5% over six months, -15.2% year to date, +3.4% in the last week.

12 Months vs Market
SNN
-20.9%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%

Over the past 12 months SNN returned -20.9% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.

Volume & Liquidity 0.53× 3-mo avg
Today 860,353 3-mo avg 1.6M
1W
975.3K
1M
1.2M
3M
1.6M
6M
1.5M
YTD
1.3M
1Y
1.1M

SNN most recently traded 860,353 shares against a 3-month average daily volume of 1.6M.

More News

Read More
News headline image
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
September 23, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System
September 22, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
September 21, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith & Nephew (NYSE:SNN) Looks Undervalued on Decent Value Screen ↗
August 28, 2026
Via Chartmill
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗
July 01, 2026
Via Chartmill
Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗
April 24, 2026
Via Chartmill
News headline image
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds
September 16, 2026
From Smith & Nephew Plc
Via ACCESS Newswire
News headline image
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds
September 15, 2026
From Smith & Nephew Plc
Via ACCESS Newswire
News headline image
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m
September 08, 2026
From Smith & Nephew Plc
Via ACCESS Newswire
News headline image
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
August 18, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
August 17, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith & Nephew SNATS Q2 Earnings Call Highlights ↗
August 09, 2026
Via MarketBeat
Topics Earnings World Trade
News headline image
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
August 05, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗
August 04, 2026
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
July 29, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
July 21, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
July 15, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
June 09, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty
June 08, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
June 01, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
May 22, 2026
From World Street Intelligence
Via GlobeNewswire
News headline image
Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026
May 05, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
April 21, 2026
From Smith & Nephew UK Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?
Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.
What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?
Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?
The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange
What is the current price of Smith & Nephew SNATS, Inc. Common Stock?
The current price of Smith & Nephew SNATS, Inc. Common Stock is 27.88
When was Smith & Nephew SNATS, Inc. Common Stock last traded?
The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 10/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap